fbpx

Merck

Nebojša Škuljec, Director, Merck Sharp & Dohme

Nebojša Škuljec, Director, Merck Sharp & Dohme

Innovative Medicines Will Save the World

Merck Sharp & Dohme is one of the top American biopharmaceutical company, a global leader in providing innovative solutions in medicines, vaccines and biologic drugs. In the US, MSD celebrates its 130th anniversary; in Serbia, 23 years of business operations
Ina Bulat, Director, Merck Serbia

Ina Bulat, Director, Merck Serbia

Merck is Leading the Way

When the Human Genome Project was completed in 2003, the cost of generating one human genome sequence stood at some 54 million U.S. dollars. Twelve years later, the same procedure costs around a thousand dollars. Our work is fuelled by the belief that science is a force for good

Science For the Future

Importance and connection of the science and society and importance of science in everyday life, were some of the topics of the scientific conference...

Sandra Marinković, Merck Sharpe & Dohme

We Are Bringing New Hope For Cancer Patients

Merck Sharpe & Dohme is an innovative global leader in the health sector that is dedicated to improving health and well-being of people around the world via innovative medicines, vaccines and biological therapies
Ina Bulat, General Manager & Managing Director SER&MNE & Regional Manager South Adriatic at Merck

Ina Bulat, General Manager & Managing Director SER&MNE & Regional Manager South Adriatic at Merck

Helping The World Be Well

Our approach is aligned with our mission and values and focuses on four key priorities: access to medicines, environmental sustainability, employee health and well-being, and ethics and transparency
error: